Cargando…
MYCN drives glutaminolysis in neuroblastoma and confers sensitivity to an ROS augmenting agent
Heightened aerobic glycolysis and glutaminolysis are characteristic metabolic phenotypes in cancer cells. Neuroblastoma (NBL), a devastating pediatric cancer, is featured by frequent genomic amplification of MYCN, a member of the Myc oncogene family that is primarily expressed in the early stage of...
Autores principales: | Wang, Tingting, Liu, Lingling, Chen, Xuyong, Shen, Yuqing, Lian, Gaojian, Shah, Nilay, Davidoff, Andrew M, Yang, Jun, Wang, Ruoning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833827/ https://www.ncbi.nlm.nih.gov/pubmed/29445162 http://dx.doi.org/10.1038/s41419-018-0295-5 |
Ejemplares similares
-
The super elongation complex drives transcriptional addiction in MYCN-amplified neuroblastoma
por: Wang, Donghai, et al.
Publicado: (2023) -
An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability
por: Nagy, Zsuzsanna, et al.
Publicado: (2021) -
MYCN Function in Neuroblastoma Development
por: Otte, Jörg, et al.
Publicado: (2021) -
MYCN and Metabolic Reprogramming in Neuroblastoma
por: Bansal, Mohit, et al.
Publicado: (2022) -
Metastasis in neuroblastoma: the MYCN question
por: Bhavsar, Swapnil Parashram
Publicado: (2023)